Posted in | News

Agilent Technologies Introduces New Single Quadrupole Mass Spectrometers

Agilent Technologies Inc. today introduced its 6100 Series of single quadrupole mass spectrometers, which comprises four new instruments, including a fast-scanning model.

Each of the single quads has a 40-percent smaller footprint (15 inches wide) than previous models and features high sensitivity, ease of use and Agilent's renowned reliability. The new instruments are also priced lower than their predecessors.

Agilent is a market leader in single-quad technology, and Agilent single quads are used in pharmaceutical and chemical analysis laboratories around the world. "As our best-selling LC/MS instrument, the Agilent single quad is the workhorse of the industry, delivering high performance day after day," said Fred Strohmeier, general manager of Agilent's Liquid Phase Analysis Business. "We have introduced the 6100 Series to give our customers more options tailored to their budgets and analytical needs -- from fast scanning of new drug compounds to quantifying trace-level environmental toxins."

The Agilent 6100 Series

  • The Agilent 6140 Single Quad is a new high-performance, fast-scanning model designed for high-throughput laboratories. With a scanning speed of 10,000 amu/second, the 6140 can keep pace with the Agilent 1200 Rapid Resolution LC system, the industry's fastest liquid chromatograph.
  • The Agilent 6130 Single Quad is the full-featured research-grade model, offering 1-picogram sensitivity, multi-signal capability and a full mass range to 3,000 amu.
  • The new Agilent 6120 Single Quad offers 10-picogram sensitivity and positive/negative switching capability, which previously was available only in Agilent's high-end single quad. The 6210 provides drug-discovery and development researchers with a cost-effective means of rapidly analyzing new compound libraries.
  • The Agilent 6110 Single Quad is the entry-level model and offers 10-picogram sensitivity. It is priced 18-percent lower than the previous model.

Like all 6000 Series instruments, the single quads feature Agilent's autotune function, which improves ease of use, uptime and productivity by eliminating the need for manual recalibration from sample to sample. They are also compatible with the broadest range of ion sources in the industry, each of them easily exchanged. This includes Agilent's proprietary multimode ion source , which is the only source on the market to provide simultaneous electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI) data. This further improves productivity by reducing the need for repeated experimental runs and producing more information per unit of time.

For more information about the 6100 Series single quads, contact your sales representative, the Agilent Customer Call Center (phone numbers by country available online at www.chem.agilent.com/scripts/cag_feedback.asp ), or visit Agilent online at www.agilent.com/chem/SQ .

Availability

The Agilent 6100 Single Quads are available for order June 1, with shipments beginning in September 2006.

Agilent in Mass Spectrometry

Agilent is a leading provider of GC/MS, LC/MS and ICP-MS technologies for organic and inorganic spectroscopy. Among the company's key products are the 5973 and 5975 inert MSDs, the 7500 Series ICP-MS systems, and the new Agilent 6000 Series LC/MS triple quadrupole, ion trap, time-of-flight and quadrupole time-of-flight instruments. Agilent provides innovative HPLC-Chip/MS technology and the broadest range of ion sources in the industry. As a leader in separations and software, Agilent can address the entire customer workflow from sample introduction through data analysis.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.